Oxford Technology 3rd Quarter Results

 
TIDMOXT 
 
 
   Oxford Technology VCT Plc -- 3(rd) Quarter Results 
 
   Oxford Technology VCT Plc presents its quarterly update for the 3 month 
period commencing 1 September 2020. 
 
   The Directors have recently reviewed the valuation of its entire 
portfolio as at 30 November 2020.  As previously advised, 236,620 shares 
in Scancell Holdings Plc (Scancell) were disposed of following the sharp 
share price rise on AIM surrounding news about the novel DNA vaccine 
against Covid-19 being worked on by Scancell. Apart from this, the 
portfolio was unchanged during the quarter. 
 
   The unaudited net asset value per ordinary share as at 30 November 2020 
was 38.6p. This represents an increase of 2.4p from the net asset value 
per ordinary share at 31 August 2020. This increase is mainly 
attributable to the rise in share price of Scancell (8.0p to 11.5p). 
 
   The total return to shareholders including previous dividends of 55.0p 
per share is now 93.6p per share. 
 
   The total number of ordinary shares in issue is 5,431,655. 
 
   The Directors are not aware of any other events or transactions which 
have taken place between 30 November 2020 and the publication of this 
statement which have had a material effect on the financial position of 
the Company. 
 
   The information above is deemed by the Company to constitute inside 
information as stipulated under the Market Abuse Regulations (EU No. 
596/2014). Upon the publication of this announcement via a Regulatory 
Information Service this inside information is now considered to be in 
the public domain. 
 
   18 December 2020 
 
   Enquiries: 
 
   Lucius Cary, Oxford Technology Management 
 
   01865 784466 
 
 
 
 

(END) Dow Jones Newswires

December 18, 2020 02:00 ET (07:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.